ELOX — Eloxx Pharmaceuticals Inc · $314 cap

Eloxx Pharmaceuticals Inc (ELOX) is a biotechnology company listed on US.

Latest reported ELOX revenue for 2025-12-31 was $0. Net income was -$6.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ELOX currently screens at market cap $314.

Use this ELOX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ELOX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ELOX SEC filings page. Lician reads the product cache first so this HTML stays unique to Eloxx Pharmaceuticals Inc even when a live quote feed is slow.

Eloxx Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full ELOX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$6.0M
  • Total Assets$5.3M
  • Total Debt$0
  • Free Cash Flow$0

ELOX recent filings